Company leadership

Wim Mol, PhD, Chief Executive Officer

Wim Mol carries over 25 years of international experience in general management, commercial and R&D positions in the pharmaceutical industry. Before joining Pepscan in 2009 he was Vice President at Schering Plough and responsible for both global scientific development and commercial strategy of a Phase III project. Prior to that he held multiple executive roles within the Organon group, as Executive Director Global Marketing for the Women’s Health portfolio, general manager of a Organon-Sanofi joint venture in the USA, and country manager positions in Chile and the Netherlands. He holds a MSc in Pharmacy and a PhD in Pharmacology, both from the University of Groningen (the Netherlands).

Peter Timmerman, PhD, Chief Scientific Officer

Peter Timmerman joined Pepscan in 2001 and is responsible for scientific developments at Pepscan and in his role as CSO drives further advances in protein mimicry for peptide drug discovery program. He is inventor of the CLIPS technology and also holds a chair as Professor (by special appointment) in Protein Mimetic Chemistry at the University of Amsterdam. He studied Chemistry at the Vrije Universiteit (Amsterdam), and obtained his PhD summa cum laude from the University of Twente. In 1995, he was recipient of the Backer Prize for the best thesis in Organic Chemistry. He did post-doctoral research at the ETH in Zürich and was Assistant Professor in Supramolecular Chemistry and Technology at the University of Twente from 1995-2001. He is co-author of over 80 scientific papers and co-inventor on >10 patents.

Evert van Dijk, BSc, Chief Operating Officer

Evert van Dijk is responsible for the manufacturing and supply chain of peptide products from Pepscan, in particular the Chemistry and Micro-array operations, as well as the worldwide peptide products and services business. As an early employee of Pepscan he has been instrumental in the development of most of Pepscan’s peptide products and services, e.g. peptide microarray technology. He was responsible for the development of the PepChip peptide array platform. His expertise is focused on protein-protein interactions and peptide chemistry, in particular solid phase peptide synthesis for antibody recognition. Mr. van Dijk has >15 years experience in executive leadership in biotech environment. He received his B.Sc. degree in Biochemistry in 1994 from the Hanze University of Applied Sciences in Groningen.

Henk van der Meer, Chief Financial Officer

Henk van der Meer joined Pepscan in September 2008 as CFO. He has over 30 years of experience in finance. He studied Business Economics at Windesheim College in the Netherlands and was further educated in Information Management. Prior to joining Pepscan he held various positions of increasing responsibility at Rijkswaterstaat and Wageningen University. He was involved in incorporation, management and financing of university spin-out companies at Wageningen University. Throughout his career, he has acquired a wealth of experience in F&C, company valuations and corporate strategy.